Finerenone in Women and Men With Heart Failure With Mildly Reduced or Preserved Ejection Fraction

This prespecified secondary analysis of a randomized clinical trial examines the efficacy and safety of finerenone in women and men with heart failure with mildly reduced ejection fraction and heart failure with preserved ejection fraction.